GSK vs. Andrx Wellbutrin SR Appeal Turns On Role Of Excipient

GlaxoSmithKline's Wellbutrin SR and Zyban patents do not cover the low-density form of the excipient HPMC used in Andrx' ANDA product, the generic company argued during a federal circuit appeals court hearing in Washington, D.C. Dec. 2

More from Archive

More from Pink Sheet